If you need more lookups,
subscriptions start at $34 USD/month.
Pierre Peeters Location
Arnhem-Nijmegen Metropolitan, GE, NL
Pierre Peeters Work
2019 -now Expert in Early Clinical Development @
2014 -2019 Chief Operations Officer @
2011 -2013 Research Director @
2009 -2011 Site Head Early Stage Development, @ Merck Sharp & Dohme
2007 -2009 Global Head within Early Clinical Research and Experimental Medicine, Oss @
2003 -2007 Executive Director Clinical Pharmacology and Kinetics @
1998 -2003 Departmental Head Clinical Pharmacology @
1988 -1998 Senior Research Scientist, Interim Manager Clinical Research Department, Senior Director Scientist @ Pharma Bio-Research B.V. (presently PRA) in Zuidlaren, The Netherlands
Pierre Peeters Education
Utrecht University, The Netherlands
PhD (Biopharmaceutics)
1985-1988
Nijmegen University, The Netherlands
Master of Science 28 January 1985 (Chemistry with two majors Biochemistry and Farmacochemistry)
1977-1985
Bisschoppelijk College” in Echt, The Netherlands 1971-1977
Pierre Peeters Skills
Protocol Development
Report Writing
Clinical Trials
Clinical Development
Clinical Pharmacology
CRO
GLP
Drug Metabolism
Biotechnology
ADME
Protocol
Neuroscience
Drug Discovery
Clinical Research
Biomarkers
Translational Medicine
Lifesciences
Pharmaceutical Industry
Drug Development
In Vivo
Pharmacology
Life Sciences
Pharmacokinetics
Pierre Peeters Summary
Pierre Peeters, based in Arnhem-Nijmegen Metropolitan Area, GE, NL, is currently a Expert in Early Clinical Development at Curare. Pierre Peeters brings experience from previous roles at Centre for Human Drug Research, Merck Sharp & Dohme and Schering-Plough Research Institute. Pierre Peeters holds a 1985 - 1988 PhD in Biopharmaceutics @ Utrecht University, The Netherlands. With a robust skill set that includes Protocol Development, Report Writing, Clinical Trials, Clinical Development, Clinical Pharmacology and more. Pierre Peeters has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Pierre Peeters?
Find contact details for 700 million professionals.